Correspondence to Editorial 2 on “genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial”
Clinical and Molecular Hepatology（2025）
Key words
liver cancer,immunotherapy,biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined